BioPorto A/S has been informed that Sparbank A/S has reduced its ownership to 1,885,000 shares with a nominal value of DKK 3,00 per share in BioPorto A/S, which represents 4.92% of the shares. Further details: Christina Tønnesen, Investor Relations Tel: +45 4529 0000 E-mail: investor@bioporto.com
Recommended Reading
-
June 15, 2026 Announcement no. 13 Grant of Warrants Copenhagen, Denmark, June 15, 2026, (GLOBE NEWSWIRE) – The Board of...
Read More -
June 9, 2026Announcement no. 12 BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback COPENHAGEN, DENMARK, June 9, 2026 – BioPorto A/S (“BioPorto”...
Read More